Harvard Bioscience, Inc.
HBIO
$0.352
-$0.0186-5.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.55M | 4.11M | 4.57M | 4.05M | 4.26M |
| Total Receivables | 13.48M | 14.87M | 12.83M | 12.49M | 15.31M |
| Inventory | 22.82M | 23.25M | 25.99M | 25.13M | 24.14M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.06M | 2.90M | 3.40M | 4.77M | 4.45M |
| Total Current Assets | 44.90M | 45.12M | 46.79M | 46.43M | 48.15M |
|
|
|||||
| Total Current Assets | 44.90M | 45.12M | 46.79M | 46.43M | 48.15M |
| Net Property, Plant & Equipment | 12.29M | 11.24M | 11.74M | 9.18M | 8.85M |
| Long-term Investments | 8.96M | 56.32M | 57.44M | 56.63M | 56.70M |
| Goodwill | 8.96M | 56.32M | 57.44M | 56.63M | 56.70M |
| Total Other Intangibles | 10.13M | 11.13M | 12.34M | 13.44M | 14.68M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.52M | 2.83M | 2.92M | 3.20M | 3.09M |
| Total Assets | 79.80M | 126.64M | 131.24M | 128.91M | 133.16M |
|
|
|||||
| Total Accounts Payable | 4.81M | 4.79M | 5.28M | 5.71M | 6.04M |
| Total Accrued Expenses | 2.64M | 2.26M | 2.73M | 2.76M | 3.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.38M | 38.11M | 4.73M | 4.78M | 4.92M |
| Total Finance Division Other Current Liabilities | 10.78M | 9.80M | 10.01M | 9.38M | 10.99M |
| Total Other Current Liabilities | 10.78M | 9.80M | 10.01M | 9.38M | 10.99M |
| Total Current Liabilities | 55.60M | 54.96M | 22.75M | 22.62M | 25.68M |
|
|
|||||
| Total Current Liabilities | 55.60M | 54.96M | 22.75M | 22.62M | 25.68M |
| Long-Term Debt | -- | -- | 34.48M | 31.96M | 31.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.23M | 6.38M | 6.71M | 4.71M | 4.56M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.13M | 1.97M | 1.99M | 2.37M | 2.23M |
| Total Liabilities | 64.97M | 63.30M | 65.92M | 61.67M | 64.35M |
|
|
|||||
| Common Stock & APIC | 237.55M | 237.02M | 236.41M | 235.34M | 233.89M |
| Retained Earnings | -208.35M | -158.01M | -158.03M | -153.23M | -150.30M |
| Treasury Stock & Other | -14.36M | -15.67M | -13.06M | -14.87M | -14.77M |
| Total Common Equity | 14.84M | 63.34M | 65.32M | 67.25M | 68.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.84M | 63.34M | 65.32M | 67.25M | 68.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.84M | 63.34M | 65.32M | 67.25M | 68.81M |
|
|
|||||